{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:07:04Z","timestamp":1786478824896,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10620-025-09660-1","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:10:12Z","timestamp":1769231412000},"page":"2681-2690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial"],"prefix":"10.1007","volume":"71","author":[{"given":"Sweta","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Uwais","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannu","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryada","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Bhujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahaj","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"9660_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley JE, Vellas B, Van Kan GA, Anker SD, Bauer JM, Bernabei R et al. Frailty consensus: a call to action. Journal of the American Medical Directors Association. 2013;14:392\u2013397.","journal-title":"Journal of the American Medical Directors Association."},{"key":"9660_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age And Ageing. 2010;39:412\u2013423.","journal-title":"Age And Ageing."},{"key":"9660_CR3","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/ajt.12762","volume":"14","author":"JC Lai","year":"2014","unstructured":"Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. American journal of transplantation. 2014;14:1870\u20131879.","journal-title":"American journal of transplantation."},{"key":"9660_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1053\/j.gastro.2019.01.028","volume":"156","author":"JC Lai","year":"2019","unstructured":"Lai JC, Rahimi RS, Verna EC, Kappus MR, Dunn MA, McAdams-DeMarco M et al. Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study. Gastroenterology. 2019;156:1675\u20131682.","journal-title":"Gastroenterology."},{"key":"9660_CR5","doi-asserted-by":"crossref","unstructured":"Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR, et al. 2016 Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Official journal of the American College of Gastroenterology| ACG.; 111(12):1768\u201375","DOI":"10.1038\/ajg.2016.336"},{"key":"9660_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/lt.22167","volume":"16","author":"EJ Carey","year":"2010","unstructured":"Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplantation. 2010;16:1373\u20131378.","journal-title":"Liver Transplantation."},{"key":"9660_CR7","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.3748\/wjg.v21.i25.7637","volume":"21","author":"HY Kim","year":"2015","unstructured":"Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World journal of gastroenterology: WJG. 2015;21:7637.","journal-title":"World journal of gastroenterology: WJG."},{"key":"9660_CR8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","volume":"44","author":"ZD Jiang","year":"2000","unstructured":"Jiang ZD, Ke S, Palazzini E, Riopel L, Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrobial agents and chemotherapy. 2000;44:2205\u20132206.","journal-title":"Antimicrobial agents and chemotherapy."},{"key":"9660_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jceh.2021.07.003","volume":"12","author":"S Singh","year":"2022","unstructured":"Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A et al. A comparison of different frailty scores and impact of frailty on outcome in patients with cirrhosis. Journal of clinical and experimental hepatology. 2022;12:398\u2013408.","journal-title":"Journal of clinical and experimental hepatology."},{"key":"9660_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","volume":"11","author":"P Puri","year":"2021","unstructured":"Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC et al. Nutrition in chronic liver disease: consensus statement of the Indian national association for study of the liver. Journal of clinical and experimental hepatology. 2021;11:97\u2013143.","journal-title":"Journal of clinical and experimental hepatology."},{"key":"9660_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1440-1746.2011.06951.x","volume":"27","author":"CD Tsien","year":"2012","unstructured":"Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. Journal of gastroenterology and hepatology. 2012;27:430\u2013441.","journal-title":"Journal of gastroenterology and hepatology."},{"key":"9660_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. Journal of hepatology. 2016;65:1232\u20131244.","journal-title":"Journal of hepatology."},{"key":"9660_CR13","doi-asserted-by":"crossref","unstructured":"Ebadi M, Burra P, Zanetto A, Montano-Loza AJ. 2023 Current treatment strategies and future possibilities for sarcopenia in cirrhosis. Journal of hepatology","DOI":"10.1016\/j.jhep.2023.01.031"},{"key":"9660_CR14","first-page":"51","volume":"14","author":"JJ Descombe","year":"1994","unstructured":"Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. International journal of clinical pharmacology research. 1994;14:51\u201356.","journal-title":"International journal of clinical pharmacology research."},{"key":"9660_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/hep.31708","volume":"74","author":"P Caraceni","year":"2021","unstructured":"Caraceni P, Vargas V, Sol\u00e0 E, Alessandria C, de Wit K, Trebicka J et al. The use of rifaximin in patients with cirrhosis. Hepatology. 2021;74:1660\u20131673.","journal-title":"Hepatology."},{"key":"9660_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2022.5157","volume":"50","author":"K Murata","year":"2022","unstructured":"Murata K, Kaji K, Nishimura N, Enomoto M, Fujimoto Y, Takeda S et al. Rifaximin enhances the L-carnitine-mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut-liver-muscle axis. International Journal of Molecular Medicine. 2022;50:1\u201315.","journal-title":"International Journal of Molecular Medicine."},{"key":"9660_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cgh.2013.12.021","volume":"12","author":"KD Mullen","year":"2014","unstructured":"Mullen KD, Sanyal AJ, Bass NM, Poordad FF, Sheikh MY, Frederick RT et al. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. Clinical Gastroenterology and Hepatology. 2014;12:1390\u20131397.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9660_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hep.29219","volume":"66","author":"JC Lai","year":"2017","unstructured":"Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564\u2013574.","journal-title":"Hepatology."},{"key":"9660_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.32157","volume":"75","author":"S Wang","year":"2022","unstructured":"Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG et al. Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology. 2022;75:600.","journal-title":"Hepatology."},{"key":"9660_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/MEG.0000000000000348","volume":"27","author":"V Gangarapu","year":"2015","unstructured":"Gangarapu V, Ince AT, Baysal B, Kayar Y, Kilic U, G\u00f6k \u00d6 et al. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. European journal of gastroenterology & hepatology. 2015;27:840\u2013845.","journal-title":"European journal of gastroenterology & hepatology."},{"key":"9660_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","volume":"76","author":"VC Patel","year":"2022","unstructured":"Patel VC, Lee S, McPhail MJ, Da Silva K, Guilly S, Zamalloa A et al. Rifaximin-\u03b1 reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. Journal of hepatology. 2022;76:332\u2013342.","journal-title":"Journal of hepatology."},{"key":"9660_CR22","doi-asserted-by":"publisher","unstructured":"Yu X, Jin Y, Zhou W, Xiao T, Wu Z, Su J, et al. Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome. Frontiers in Cellular and Infection Microbiology [Internet]. 2022;11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcimb.2021.761192","DOI":"10.3389\/fcimb.2021.761192"},{"key":"9660_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jgh.16035","volume":"38","author":"BL Meena","year":"2023","unstructured":"Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U et al. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial. Journal of gastroenterology and hepatology. 2023;38:210\u2013218.","journal-title":"Journal of gastroenterology and hepatology."},{"key":"9660_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.10.002","volume":"14","author":"S Swaroop","year":"2024","unstructured":"Swaroop S, Vaishnav M, Arora U, Biswas S, Aggarwal A, Sarkar S et al. Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis. Journal of clinical and experimental hepatology. 2024;14:101291.","journal-title":"Journal of clinical and experimental hepatology."},{"key":"9660_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.14309\/ajg.0000000000001113","volume":"116","author":"JC Lai","year":"2021","unstructured":"Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL et al. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol. 2021;116:717\u2013722.","journal-title":"Am J Gastroenterol."},{"key":"9660_CR26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","volume":"74","author":"JC Lai","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md). 2021;74:1611.","journal-title":"Hepatology (Baltimore, Md)."},{"key":"9660_CR27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.amjmed.2021.07.012","volume":"134","author":"M Mehta","year":"2021","unstructured":"Mehta M, Louissaint J, Parikh NS, Long MT, Tapper EB. Cognitive Function, Sarcopenia, and Inflammation Are Strongly Associated with Frailty: A Framingham Cohort Study. Am J Med. 2021;134:1530\u20131538.","journal-title":"Am J Med."},{"key":"9660_CR28","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2169\/internalmedicine.5094-20","volume":"59","author":"T Ishikawa","year":"2020","unstructured":"Ishikawa T, Endo S, Imai M, Azumi M, Nozawa Y, Sano T et al. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy. Intern Med. 2020;59:2465\u20132469.","journal-title":"Intern Med."},{"key":"9660_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2213-8587(18)30110-4","volume":"6","author":"A Clegg","year":"2018","unstructured":"Clegg A, Hassan-Smith Z. Frailty and the endocrine system. The lancet Diabetes & endocrinology. 2018;6:743\u2013752.","journal-title":"The lancet Diabetes & endocrinology."},{"key":"9660_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187176","volume":"12","author":"SS Rogal","year":"2017","unstructured":"Rogal SS, Udawatta V, Akpan I, Moghe A, Chidi A, Shetty A et al. Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. PLOS ONE. 2017;12:e0187176.","journal-title":"PLOS ONE."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09660-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:05:35Z","timestamp":1786061135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09660-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9660"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09660-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}